Posted inBiotechnology
Lonza’s Synaffix adds Boehringer to its constellation of partners with $1.3B ADC tech pact
After inking a series of partnerships late last year, Lonza’s antibody-drug conjugate (ADC) specialist Synaffix is kicking off 2025 with…







